Phage Therapy in Solid Organ Transplant Recipients – State of the Evidence and Future Directions

Wednesday, January 17, 2024 - 15:00 to 16:00

VIEW ON-DEMAND

After participating in this webinar, the attendee will be able to:

  1. Describe the current experience with bacteriophage therapy (history, safety, effectiveness)
  2. Describe challenges in treating SOT recipients with phages, including persons with LVADs and CF
  3. Understand the current research and clinical trial landscape to bring phages to the mainstream

Speakers:

  • Saima Aslam, MD, MS, FAST • Professor of Medicine and Clinical Lead, Center for Innovative Phage Applications and Therapeutics, University of California San Diego, La Jolla, CA
  • Ghady Haidar, MD • Assistant Professor of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA

Moderator:

  • Raymund Razonable, MD, FAST • Professor of Medicine and Vice Chair, Infectious Diseases, Mayo Clinic College of Medicine & Science, Rochester, MN
- - - - -

The AST Education Committee would like to thank the Infectious Disease Community of Practice (IDCOP) for suggesting this topic as part of the 2023-2024 T3 webinar series. Learn more about AST's COPs at www.myast.org/cops .

Education Category: 
Series category: 
T3: Timely Topics in Transplantion

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.